252 related articles for article (PubMed ID: 33410948)
1. Feasibility of generalised diffusion kurtosis imaging approach for brain glioma grading.
Pogosbekian EL; Pronin IN; Zakharova NE; Batalov AI; Turkin AM; Konakova TA; Maximov II
Neuroradiology; 2021 Aug; 63(8):1241-1251. PubMed ID: 33410948
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of the diffusion kurtosis imaging and diffusion tensor imaging in grading gliomas, predicting tumour cell proliferation and IDH-1 gene mutation status.
Zhao J; Wang YL; Li XB; Hu MS; Li ZH; Song YK; Wang JY; Tian YS; Liu DW; Yan X; Jiang L; Yang ZY; Chu JP
J Neurooncol; 2019 Jan; 141(1):195-203. PubMed ID: 30414095
[TBL] [Abstract][Full Text] [Related]
3. Assessment of tissue heterogeneity using diffusion tensor and diffusion kurtosis imaging for grading gliomas.
Raja R; Sinha N; Saini J; Mahadevan A; Rao KN; Swaminathan A
Neuroradiology; 2016 Dec; 58(12):1217-1231. PubMed ID: 27796448
[TBL] [Abstract][Full Text] [Related]
4. Histogram analysis of diffusion kurtosis imaging derived maps may distinguish between low and high grade gliomas before surgery.
Qi XX; Shi DF; Ren SX; Zhang SY; Li L; Li QC; Guan LM
Eur Radiol; 2018 Apr; 28(4):1748-1755. PubMed ID: 29143940
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of glioma malignancy grade using diffusion MRI.
Maximov II; Tonoyan AS; Pronin IN
Phys Med; 2017 Aug; 40():24-32. PubMed ID: 28712716
[TBL] [Abstract][Full Text] [Related]
6. Diffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation.
Jiang R; Jiang J; Zhao L; Zhang J; Zhang S; Yao Y; Yang S; Shi J; Shen N; Su C; Zhang J; Zhu W
Oncotarget; 2015 Dec; 6(39):42380-93. PubMed ID: 26544514
[TBL] [Abstract][Full Text] [Related]
7. Diffusion kurtosis imaging in evaluating gliomas: different region of interest selection methods on time efficiency, measurement repeatability, and diagnostic ability.
Chu JP; Song YK; Tian YS; Qiu HS; Huang XH; Wang YL; Huang YQ; Zhao J
Eur Radiol; 2021 Feb; 31(2):729-739. PubMed ID: 32857204
[TBL] [Abstract][Full Text] [Related]
8. Developing a Predictive Grading Model for Children with Gliomas Based on Diffusion Kurtosis Imaging Metrics: Accuracy and Clinical Correlations with Patient Survival.
Voicu IP; Napolitano A; Caulo M; Dotta F; Piccirilli E; Vinci M; Diomedi-Camassei F; Lattavo L; Carboni A; Miele E; Cacchione A; Carai A; Tomà P; Mastronuzzi A; Colafati GS
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230701
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance between MR amide proton transfer (APT) and diffusion kurtosis imaging (DKI) in glioma grading and IDH mutation status prediction at 3 T.
Xu Z; Ke C; Liu J; Xu S; Han L; Yang Y; Qian L; Liu X; Zheng H; Lv X; Wu Y
Eur J Radiol; 2021 Jan; 134():109466. PubMed ID: 33307459
[TBL] [Abstract][Full Text] [Related]
10. Diffusion kurtosis imaging as an imaging biomarker for predicting prognosis of the patients with high-grade gliomas.
Wang X; Gao W; Li F; Shi W; Li H; Zeng Q
Magn Reson Imaging; 2019 Nov; 63():131-136. PubMed ID: 31425809
[TBL] [Abstract][Full Text] [Related]
11. Value of diffusion kurtosis imaging in assessing low-grade gliomas.
Goryawala MZ; Heros DO; Komotar RJ; Sheriff S; Saraf-Lavi E; Maudsley AA
J Magn Reson Imaging; 2018 Dec; 48(6):1551-1558. PubMed ID: 29573042
[TBL] [Abstract][Full Text] [Related]
12. Application of diffusion kurtosis imaging to the study of edema in solid and peritumoral areas of glioma.
Qiu J; Deng K; Wang P; Chen C; Luo Y; Yuan S; Wen J
Magn Reson Imaging; 2022 Feb; 86():10-16. PubMed ID: 34793876
[TBL] [Abstract][Full Text] [Related]
13. The role of MR diffusion kurtosis and neurite orientation dispersion and density imaging in evaluating gliomas.
Genç B; Aslan K; Özçağlayan A; İncesu L
J Neuroimaging; 2023; 33(4):644-651. PubMed ID: 37170070
[TBL] [Abstract][Full Text] [Related]
14. In vivo assessment of tumor heterogeneity in WHO 2016 glioma grades using diffusion kurtosis imaging: Diagnostic performance and improvement of feasibility in routine clinical practice.
Hempel JM; Schittenhelm J; Bisdas S; Brendle C; Bender B; Bier G; Skardelly M; Tabatabai G; Castaneda Vega S; Ernemann U; Klose U
J Neuroradiol; 2018 Feb; 45(1):32-40. PubMed ID: 28865921
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cerebral glioma using 3T diffusion kurtosis tensor imaging and the relationship between diffusion kurtosis metrics and tumor cellularity.
Qi C; Yang S; Meng L; Chen H; Li Z; Wang S; Jiang T; Li S
J Int Med Res; 2017 Aug; 45(4):1347-1358. PubMed ID: 28587542
[TBL] [Abstract][Full Text] [Related]
16. Differentiation between high-grade gliomas and solitary brain metastases: a comparison of five diffusion-weighted MRI models.
Mao J; Zeng W; Zhang Q; Yang Z; Yan X; Zhang H; Wang M; Yang G; Zhou M; Shen J
BMC Med Imaging; 2020 Nov; 20(1):124. PubMed ID: 33228564
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of diffuse glioma grade and proliferation activity by different diffusion-weighted-imaging models including diffusion kurtosis imaging (DKI) and mean apparent propagator (MAP) MRI.
Xie SH; Lang R; Li B; Zhao H; Wang P; He JL; Ma XY; Wu Q; Wang SY; Zhang HP; Gao Y; Wu JL
Neuroradiology; 2023 Jan; 65(1):55-64. PubMed ID: 35835879
[TBL] [Abstract][Full Text] [Related]
18. Differentiating high-grade glioma recurrence from pseudoprogression: Comparing diffusion kurtosis imaging and diffusion tensor imaging.
Wu XF; Liang X; Wang XC; Qin JB; Zhang L; Tan Y; Zhang H
Eur J Radiol; 2021 Feb; 135():109445. PubMed ID: 33341429
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of MR diffusion kurtosis imaging for differentiating low-grade from high-grade glioma before surgery: A systematic review and meta-analysis.
Xu C; Li C; Xing C; Li J; Jiang X
Clin Neurol Neurosurg; 2022 Sep; 220():107373. PubMed ID: 35878557
[TBL] [Abstract][Full Text] [Related]
20. Grading meningiomas with diffusion metrics: a comparison between diffusion kurtosis, mean apparent propagator, neurite orientation dispersion and density, and diffusion tensor imaging.
She D; Huang H; Guo W; Jiang D; Zhao X; Kang Y; Cao D
Eur Radiol; 2023 May; 33(5):3671-3681. PubMed ID: 36897347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
